GO:0005249 voltage-gated potassium channel activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0005249 voltage-gated potassium channel activity describes the molecular function that enables potassium ions to cross membranes through channels whose opening depends on the voltage across the membrane.
• Voltage-gated potassium channels cycle through resting, intermediate, open, and inactivated states, and a physiologically relevant intermediate state structure has been resolved.
• Channel opening and closing are shaped by charged lipids in a leaflet-specific manner, showing that the lipid environment is part of the gating mechanism.
• Inactivation is a structurally interpretable process that limits potassium flux after opening and is central to channel physiology.
• Peptide and small-molecule modulators, including ShK-like peptides and artificial pore blockers, can selectively target voltage-gated potassium channel isoforms.
• Dysregulated voltage-gated potassium channel activity is linked to immune, cardiovascular, and neurological disease contexts, making these channels active drug and research targets.
Description
GO:0005249 voltage-gated potassium channel activity is a molecular function term in the Gene Ontology that describes the transmembrane transfer of a potassium ion through a voltage-gated channel, where the open state depends on the voltage across the membrane. This activity is fundamental to excitable cells because it controls potassium flux and thereby shapes membrane potential, action potential repolarization, and cellular signaling. Researchers study this term to connect channel biophysics to physiology, pharmacology, and disease mechanisms. Structural and functional work has revealed that voltage-gated potassium channels are not simple two-state switches; they occupy multiple conformations, including a physiologically relevant intermediate state that has been captured structurally. Inactivation is also a structurally interpretable process that determines how long potassium conductance persists after activation. Beyond the protein itself, the surrounding lipid bilayer influences gating, and charged lipids exert leaflet-specific effects on channel behavior. Pharmacological and peptide tools, such as ShK-like peptides and artificial pore blockers, allow selective interrogation of specific channel isoforms. Because these channels participate in immune, cardiovascular, and neurological processes, they are important targets for mechanistic research and therapeutic development.
voltage-gated potassium channel activity At A Glance
| GO ID | GO:0005249 |
|---|---|
| GO term | voltage-gated potassium channel activity |
| Ontology | molecular_function |
| Synonym | voltage-dependent potassium channel activity; voltage gated potassium channel activity; voltage-gated potassium ion channel activity; voltage-sensitive potassium channel |
| Major function | Enables transmembrane transfer of a potassium ion by a voltage-gated channel whose open state depends on membrane voltage |
| Gating states | Resting, intermediate, open, and inactivated states have been described, with an intermediate state structure resolved |
| Inactivation | A structurally interpretable process that limits potassium conductance after channel opening |
| Lipid sensitivity | Charged lipids affect the channel in a leaflet-specific manner |
| Pharmacology | Peptide blockers and artificial pore blockers can selectively target channel isoforms |
What Is GO:0005249?
In plain terms, GO:0005249 voltage-gated potassium channel activity is the function that lets potassium ions move across a membrane through a channel that opens in response to changes in membrane voltage. The channel is not always open; its open state is controlled by the voltage difference across the membrane in which it sits. This activity therefore couples electrical signals to potassium ion flow, which is why it is central to electrical signaling and potassium homeostasis in cells.
Why Is voltage-gated potassium channel activity Important in Cell Biology?
Voltage-gated potassium channel activity is important because it converts membrane voltage changes into potassium ion flux, a process that underlies electrical signaling, action potential repolarization, and cellular excitability. Because the channel open state is voltage-dependent, it provides a feedback mechanism that shapes the duration and amplitude of electrical signals. Inactivation adds another layer of control by limiting potassium conductance after opening, which is critical for normal physiological timing. The lipid environment further tunes this activity, and charged lipids can influence the channel in a leaflet-specific way. Pharmacological tools such as ShK-like peptides and artificial pore blockers demonstrate that this activity can be selectively modulated, which is important for both basic research and drug discovery. Dysregulation of voltage-gated potassium channel activity has been connected to immune and cardiovascular contexts, including HIV-1-infected macrophages and cardiac remodeling.
• Controls potassium ion flux across membranes in response to voltage, shaping membrane potential and electrical signaling.
• Supports action potential repolarization and the timing of electrical events in excitable cells.
• Inactivation provides a built-in brake that limits potassium conductance after opening.
• The lipid bilayer, especially charged lipids, modulates channel behavior in a leaflet-specific manner.
• Peptide modulators such as ShK-like peptides can block human voltage-gated potassium channels.
• Artificial pore blockers can act specifically on a voltage-gated potassium channel isoform such as Kv1.6.
• Voltage-gated potassium channel modulation affects neurotoxic activity in HIV-1-infected macrophages.
• Inhibition of Kv1.5 by hydrogen sulfide attenuates remodeling through S-nitrosylation-mediated signaling.
• Provides targets for pharmacological intervention in immune, cardiovascular, and neurological research.
• Offers structural and mechanistic insights into gating and inactivation for rational modulator design.
Mechanism, Genes and Research Methods
Voltage sensing and the intermediate state
In simple terms: The channel senses voltage and passes through an intermediate shape before it fully opens.
Voltage-gated potassium channels respond to changes in membrane voltage, and their open state depends on the voltage across the membrane. A physiologically relevant intermediate state structure of a voltage-gated potassium channel has been resolved, showing that gating is not a simple two-state process. This intermediate state helps explain how the channel transitions between resting and open conformations.
Opening and potassium flux
In simple terms: When the channel opens, potassium ions flow through it.
The defining activity of GO:0005249 is the transmembrane transfer of a potassium ion by a voltage-gated channel. Once the channel adopts an open state, potassium ions move across the membrane, which changes the electrical and chemical gradients of the cell. This flux is the functional output of the molecular function described by the term.
Inactivation
In simple terms: After opening, the channel can shut itself down in a process called inactivation.
Inactivation is a structurally interpretable process that limits potassium conductance after the channel has opened. It is a key determinant of how long the channel remains conductive and therefore shapes the physiological impact of voltage-gated potassium channel activity. Structural interpretations of inactivation provide a framework for understanding this regulatory step.
Lipid-dependent modulation
In simple terms: The fats around the channel can change how it behaves.
Charged lipids exert leaflet-specific effects on a voltage-gated potassium channel, meaning that the lipid composition on each side of the membrane can differentially influence channel function. This shows that the activity of GO:0005249 is not determined by protein structure alone but is also tuned by the membrane environment.
Pharmacological modulation by peptides and blockers
In simple terms: Natural peptides and synthetic blockers can turn the channel off or on.
A synthetic ShK-like peptide from the jellyfish Nemopilema nomurai has human voltage-gated potassium-channel-blocking activity, demonstrating that peptide scaffolds can target this function. An artificial pore blocker acts specifically on the voltage-gated potassium channel isoform Kv1.6, showing that isoform-selective blockade is achievable. These tools are valuable for probing the role of GO:0005249 in cells and tissues.
Key Genes Involved in GO:0005249 voltage-gated potassium channel activity
The following genes and proteins are experimentally linked to voltage-gated potassium channel activity and its modulation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| Kv1.5 (KCNA5) | Voltage-gated potassium channel isoform whose inhibition by hydrogen sulfide attenuates remodeling through S-nitrosylation-mediated signaling | Cardiovascular remodeling research and pharmacological modulation |
| Kv1.6 (KCNA6) | Voltage-gated potassium channel isoform targeted by an artificial pore blocker | Isoform-selective blocker development and electrophysiology |
| Kv channel (unspecified isoform) | Voltage-gated potassium channel whose intermediate state structure was resolved | Structural biology of gating and intermediate states |
| Kv channel (unspecified isoform) | Voltage-gated potassium channel subject to leaflet-specific charged lipid effects | Membrane lipid interaction studies |
| Kv channel (unspecified isoform) | Voltage-gated potassium channel with structurally interpreted inactivation | Mechanistic studies of inactivation |
| Kv channel (unspecified isoform) | Voltage-gated potassium channel activated by amphiphilic glycopeptides | Peptide-based activation research |
| ShK-like peptide target | Human voltage-gated potassium channel blocked by a synthetic ShK-like peptide from Nemopilema nomurai | Venom-derived peptide drug discovery |
| Macrophage Kv channel | Voltage-gated potassium channel modulation of neurotoxic activity in HIV-1-infected macrophages | Neuroimmune disease research |
| Kv1.5 signaling axis | Kv1.5 inhibition linked to S-nitrosylation-mediated signaling | Redox and nitrosylation biology |
| Kv1.6 pore region | Site of action for an artificial pore blocker | Pore-blocker design and selectivity studies |
| Kv voltage sensor | Domain that senses membrane voltage and controls open state | Structure-function studies of voltage sensing |
| Kv inactivation gate | Structural element responsible for inactivation | Inactivation mechanism research |
| Kv lipid-facing surface | Region affected by charged lipids in a leaflet-specific manner | Lipid-protein interaction mapping |
| Kv glycopeptide binding site | Site through which amphiphilic glycopeptides activate the channel | Chemical biology of channel activation |
| Kv peptide blocker site | Site targeted by ShK-like peptide | Peptide blocker characterization |
| Kv neurotoxic signaling node | Channel activity that modulates neurotoxic activity in HIV-1-infected macrophages | Neuroimmune pharmacology |
How Is voltage-gated potassium channel activity Regulated?
Voltage-gated potassium channel activity is regulated by multiple layers. The open state itself is controlled by the voltage across the membrane, which is the defining feature of GO:0005249. Inactivation provides a secondary regulatory step that limits conductance after opening and is structurally interpretable. The lipid environment adds another regulatory layer, as charged lipids exert leaflet-specific effects on the channel. Pharmacological regulation is also possible: amphiphilic glycopeptides can activate the channel, ShK-like peptides can block it, and artificial pore blockers can act isoform-specifically. In addition, inhibition of Kv1.5 by hydrogen sulfide attenuates remodeling through S-nitrosylation-mediated signaling, linking redox regulation to channel function. Modulation of voltage-gated potassium channels also affects neurotoxic activity in HIV-1-infected macrophages, indicating that immune signaling can influence this activity.
voltage-gated potassium channel activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| Kv1.5 (KCNA5) | Cardiovascular remodeling attenuated by hydrogen sulfide through S-nitrosylation-mediated signaling | Knockout or point-mutation models to test S-nitrosylation sites |
| Macrophage Kv channel | Neurotoxic activity in HIV-1-infected macrophages | Knockout or overexpression in macrophage cell models |
| Kv1.6 (KCNA6) | Isoform-specific blockade by an artificial pore blocker | Point-mutation models of the pore region |
| Kv channel (unspecified isoform) | Gating and inactivation defects relevant to channelopathies | Knock-in models of intermediate-state or inactivation mutants |
| Kv channel (unspecified isoform) | Lipid-dependent modulation relevant to membrane biology | Overexpression models with altered lipid environments |
Neuroimmune disease and HIV-1
Voltage-gated potassium channel modulation affects neurotoxic activity in human immunodeficiency virus type-1-infected macrophages, suggesting that this molecular function participates in neuroimmune pathology. This connection makes the channel a potential node for understanding how HIV-1 infection leads to neuronal damage.
Cardiovascular remodeling
Inhibition of the voltage-gated potassium channel Kv1.5 by hydrogen sulfide attenuates remodeling through S-nitrosylation-mediated signaling. This links GO:0005249 activity to cardiovascular remodeling and identifies Kv1.5 as a potential target in this context.
Channel modulation as a therapeutic strategy
Peptide and small-molecule modulators of voltage-gated potassium channels, including ShK-like peptides and artificial pore blockers, demonstrate that this activity can be selectively targeted. Such tools support the development of therapeutics aimed at channel-related disease processes.
From voltage-gated potassium channel activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a specific Kv channel alter potassium flux and membrane potential? | Knockout cell model |
| Which residue controls voltage sensing or the intermediate state? | Point-mutation knock-in model |
| How does inactivation gate structure affect conductance? | Knock-in of inactivation-domain mutations |
| Can a tagged channel be tracked in live cells? | Tagged knock-in model |
| Does overexpression of a Kv isoform change cellular behavior? | Overexpression cell model |
| Can an isoform-selective blocker be tested against a specific channel? | Point-mutation or knockout model of the target isoform |
How to Study the voltage-gated potassium channel activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Electrophysiology | Voltage-dependent potassium currents and gating states | Characterizing open, intermediate, and inactivated states |
| Structural biology | Three-dimensional channel conformations | Resolving intermediate and inactivated states |
| Lipid interaction assays | Leaflet-specific effects of charged lipids | Testing membrane lipid modulation |
| Peptide blocker assays | Blocking activity of ShK-like peptides | Venom-derived peptide characterization |
| Pore blocker assays | Isoform-specific blockade, e.g., Kv1.6 | Selectivity testing of artificial blockers |
| Glycopeptide activation assays | Channel activation by amphiphilic glycopeptides | Chemical activation studies |
| S-nitrosylation signaling assays | Redox-linked regulation of Kv1.5 | Cardiovascular remodeling research |
| Macrophage neurotoxicity assays | Modulation of neurotoxic activity in HIV-1-infected macrophages | Neuroimmune disease modeling |
Electrophysiology
Electrophysiological recording is the direct way to measure voltage-gated potassium channel activity, because the open state depends on membrane voltage. Such measurements can resolve intermediate states and inactivation behavior that define the function.
Structural biology
Structural approaches have resolved a physiologically relevant intermediate state of a voltage-gated potassium channel, providing mechanistic insight into gating. Structural interpretation of inactivation also helps explain how conductance is limited after opening.
Lipid interaction studies
Because charged lipids exert leaflet-specific effects on a voltage-gated potassium channel, lipid interaction studies are needed to understand how the membrane environment tunes this activity.
Pharmacological profiling
Peptide and small-molecule modulators, including ShK-like peptides and artificial pore blockers, can be used to profile channel activity and isoform selectivity. Amphiphilic glycopeptides that activate the channel provide additional chemical tools.
How CRISPR Can Be Used to Study GO:0005249 voltage-gated potassium channel activity
Knockout
CRISPR knockout can remove a specific voltage-gated potassium channel gene to test whether it is required for potassium flux, membrane potential, or a disease phenotype. For example, knocking out Kv1.5 would help determine whether its inhibition by hydrogen sulfide is necessary for attenuated remodeling.
Point Mutation
Point mutation models can alter voltage-sensing or inactivation residues to test their role in gating and conductance. Such models are useful for dissecting intermediate-state transitions and inactivation mechanisms.
Knock-in
Knock-in can introduce tagged or disease-relevant variants of a voltage-gated potassium channel to study localization, trafficking, and function in a native context. This is particularly valuable for linking structural states to cellular behavior.
Overexpression
Overexpression of a voltage-gated potassium channel can amplify potassium currents and reveal downstream effects on cell physiology. It is also useful for testing pharmacological modulators such as peptides and pore blockers.
How EDITGENE Supports voltage-gated potassium channel activity Research
Researchers studying voltage-gated potassium channel activity-related genes often need to determine whether a candidate gene is causally involved in channel function, gating, or disease phenotypes. EDITGENE provides CRISPR-based cell models and screening services that allow precise manipulation of these genes in relevant cellular contexts.
Contact EDITGENE today to design your custom CRISPR model for voltage-gated potassium channel activity research.
Frequently Asked Questions About voltage-gated potassium channel activity
What is GO:0005249 voltage-gated potassium channel activity?
It is a Gene Ontology molecular function term describing the transmembrane transfer of a potassium ion by a voltage-gated channel whose open state depends on the voltage across the membrane.
What genes are involved in voltage-gated potassium channel activity?
Genes encoding potassium channel isoforms such as KCNA5 (Kv1.5) and KCNA6 (Kv1.6) are experimentally linked to this activity and its modulation.
How is voltage-gated potassium channel activity regulated?
It is regulated by membrane voltage, inactivation, charged lipids in a leaflet-specific manner, and pharmacological modulators such as peptides and pore blockers.
What is the role of inactivation in voltage-gated potassium channels?
Inactivation is a structurally interpretable process that limits potassium conductance after the channel opens.
Can peptides block voltage-gated potassium channels?
Yes, a synthetic ShK-like peptide from the jellyfish Nemopilema nomurai has human voltage-gated potassium-channel-blocking activity.
What diseases are linked to voltage-gated potassium channel activity?
It has been linked to neurotoxic activity in HIV-1-infected macrophages and to cardiovascular remodeling through Kv1.5 inhibition.
How do charged lipids affect voltage-gated potassium channels?
Charged lipids exert leaflet-specific effects on a voltage-gated potassium channel, meaning each side of the membrane can influence the channel differently.
What is an intermediate state in voltage-gated potassium channel gating?
It is a physiologically relevant conformation between resting and open states that has been resolved structurally.
Can artificial pore blockers target specific potassium channel isoforms?
Yes, an artificial pore blocker acts specifically on the voltage-gated potassium channel isoform Kv1.6.
How can CRISPR help study voltage-gated potassium channel activity?
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of channel genes in cellular systems.
Conclusion
GO:0005249 voltage-gated potassium channel activity is a central molecular function that links membrane voltage to potassium ion flux. Structural, biophysical, and pharmacological studies have revealed intermediate states, inactivation mechanisms, lipid sensitivity, and druggable sites on these channels. Because this activity participates in neuroimmune and cardiovascular processes, it remains an important target for mechanistic research and therapeutic development. CRISPR-based cell models and screening approaches provide powerful tools to dissect the causal roles of specific channel genes in health and disease.
References
- 1. Kyriakis E et al.. 2025. A physiologically-relevant intermediate state structure of a voltage-gated potassium channel.. Nat Commun 16(1):8814 PMID: 41044058
- 2. Irvine E et al.. 2007. Voltage-gated potassium channel modulation of neurotoxic activity in human immunodeficiency virus type-1(HIV-1)-infected macrophages.. J Neuroimmune Pharmacol 2(3):265-9 PMID: 18040860
- 3. Anand S et al.. 2025. Activation of the Voltage-Gated Potassium Channel by Amphiphilic Glycopeptides.. Chemistry 31(13):e202403943 PMID: 39836913
- 4. Kim YJ et al.. 2024. Synthetic ShK-like Peptide from the Jellyfish Nemopilema nomurai Has Human Voltage-Gated Potassium-Channel-Blocking Activity.. Mar Drugs 22(5) PMID: 38786608
- 5. Kurata HT et al.. 2006. A structural interpretation of voltage-gated potassium channel inactivation.. Prog Biophys Mol Biol 92(2):185-208 PMID: 16316679
- 6. Al-Owais MM et al.. 2023. Inhibition of the voltage-gated potassium channel Kv1.5 by hydrogen sulfide attenuates remodeling through S-nitrosylation-mediated signaling.. Commun Biol 6(1):651 PMID: 37336943
- 7. Maki T et al.. 2025. Leaflet-specific effects of charged lipids on a voltage-gated potassium channel.. J Lipid Res 66(12):100934 PMID: 41192482
- 8. Gigolaev AM et al.. 2022. Artificial pore blocker acts specifically on voltage-gated potassium channel isoform K(V)1.6.. J Biol Chem 298(11):102467 PMID: 36087839
